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IOLOGY CONTRIBUTION
NONINVASIVE MONITORING OF RADIOTHERAPY-INDUCED
MICROVASCULAR CHANGES USING DYNAMIC CONTRAST ENHANCED
MAGNETIC RESONANCE IMAGING (DCE-MRI) IN A COLORECTAL
TUMOR MODEL
WIM CEELEN, M.D.,* PETER SMEETS, M.D.,† WALTER BACKES, PH.D.,‡ NANCY VAN DAMME, PH.D.,§
TOM BOTERBERG, M.D., PH.D., PIETER DEMETTER, M.D., PH.D.,¶ ISABEL BOUCKENOOGHE,*
MARIEKE DE VISSCHERE,* MARC PEETERS, M.D., PH.D.,§ AND PIET PATTYN, M.D., PH.D.*
Departments of *Surgery, †Radiology, §Gastroenterology, and Radiotherapy, Ghent University Hospital, Ghent, Belgium;
¶Department of Pathology, Erasmus University Hospital, Brussels, Belgium; ‡Department of Radiology, Maastricht University
Hospital, Maastricht, The Netherlands
Purpose: To examine dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with a macromolec-
ular contrast agent (P792) to visualize effects of radiotherapy (RT) on microvascular leakage in a colorectal
cancer model.
Methods and Materials: CC531 tumors were induced in WAG/Rij rats. DCE-MRI was performed before and 5
days after 5  5 Gy of RT and parametric maps generated of the endothelial transfer constant (Ktrans) and the
fractional interstitial space (Ve) according to the Tofts model. Tissue pO2 mapping was performed in each tumor
core and rim before and after RT. Microvessel density (MVD), vascular endothelial growth factor (VEGF)
expression, and pimonidazole hypoxia staining were compared with a control group of tumor-bearing rats.
Results: Mean Ktrans and ve were significantly reduced after RT in all tumor regions. Mean pO2 was 6.8 mm Hg
before RT vs. 7.7 mm Hg after RT (p < 0.001) in the tumor rim and 3.5 mm Hg before RT vs. 4.4 mm Hg after
RT (p < 0.001) in the tumor core. Mean MVD in the tumor rim was 10.4 in the RT treated group vs. 16.9 in the
control group (p 0.061). VEGF expression was significantly higher in RT-treated rats. After RT, no correlation
was found between DCE-MRI parameters and histologic parameters. A correlation was seen after RT between
pO2 and Ktrans (r  0.57, p  0.08) and between pO2 and ve (r  0.65, p  0.04).
Conclusions: Dynamic contrast-enhanced-MRI with P792 allows quantification of microvascular changes in this
colorectal model. RT significantly reduces neovascular leakage and enhances tissue oxygenation and VEGF
expression. After RT, DCE-MRI parameters are related to tumor pO2, but not to MVD or VEGF expression.
© 2006 Elsevier Inc.Colorectal, Magnetic resonance, DCE-MRI, Radiotherapy.
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HINTRODUCTION
olorectal cancer remains one of the leading causes of cancer
eath in the Western world (1). Because of the specific
natomy and biology of low rectal cancer, surgical resection
lone historically has been associated with a high incidence
f locally recurrent disease. Neoadjuvant combined modal-
ty treatment has been shown to decrease local recurrence
ates even with the use of optimal surgical technique (total
esorectal excision) (2, 3). Potential disadvantages of neo-
djuvant chemoradiation include overtreatment of over-
taged disease, treatment-related toxicity, and long-term
ffects on sphincter function (4). There is therefore a need
Reprint requests to: W. Ceelen, M.D., Department of Surgery
K12 IC, Ghent University Hospital, De Pintelaan 185, B-9000
hent, Belgium. Tel: (32) 9-240 62 51; Fax: (32) 9-240 38 91;
-mail: Wim.ceelen@ugent.be
cknowledgments—The CC531 cells were kindly provided by the
aboratory of Cell Biology and Histology, Free University of Brus- A
1188or noninvasive imaging techniques that allow clinicians to
redict and monitor tumor response to neoadjuvant therapy.
Magnetic resonance imaging (MRI) recently has evolved
s one of the most promising imaging modalities in the
iagnosis and staging of rectal cancer (5). Dynamic con-
rast-enhanced magnetic resonance imaging (DCE-MRI) us-
ng paramagnetic contrast agent administration allows one
o analyze tumor specific enhancement patterns that are
overned by physiologic properties such as microvascular
ow, endothelial permeability, and size of the extracellular
xtravascular space (EES) (6). Quantitative analysis of the
nhancement signal using a pharmacokinetic model can gen-
els, Belgium. Gadomelitol (P792) was kindly provided by Guerbet
Roissy, France), who did not provide any other financial or material
upport to this study. We thank Louis Cesteleyn and Philippe
outmeyers for their technical assistance during the experiments.
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1189DCE-MRI in a colorectal tumor model ● W. CEELEN et al.rate estimates for parameters such as the endothelial transfer
oefficient Ktrans (7). The MRI contrast agents in clinical use
ave a low (1 kD) molecular weight and diffuse readily
cross the endothelial barrier of both normal and neoplastic
issues and therefore are much less suited to characterize hy-
erpermeable neoplastic vessels (8). Macromolecular weight
ontrast media take advantage of the selective hyperpermeabil-
ty of neoplastic vessels to macromolecules and have been used
uccessfully to monitor angiogenesis and the effects of antian-
iogenesis agents in preclinical studies (9). For macromolec-
lar agents, microvascular leakage determined by Ktrans is
elatively flow independent and therefore estimation of leakage
hanges as a surrogate marker of angiogenesis is possible
ithout exact measurement of capillary flow (10).
We studied the changes in neovascular leakage of an exper-
mental colorectal cancer during fractionated radiotherapy
RT) using DCE-MRI with P792, a new macromolecular MRI
ontrast agent (CA) evaluated in phase II clinical trials. Non-
nvasive imaging was compared with invasive tissue pO2 mea-
urement, microvessel counts, vascular endothelial growth fac-
or (VEGF) expression, and pimonidazole hypoxia staining.
METHODS AND MATERIALS
The experimental protocol was reviewed and approved by the
nimal Ethical Committee of the Ghent University, Belgium.
nimals and tumor model
A group of 11 male Wag/Rij rats (Harlan, Horst, The Nether-
ands) was studied longitudinally with DCE-MRI and invasive
xygenation measurements performed both before and 5 days after
ompletion of RT. For histology and immunohistochemistry, this
roup was compared with nine untreated control rats bearing
umors of similar size. The CC531 cell line is a 1,2-dimethylhy-
razine-induced, moderately differentiated, and weakly immuno-
enic colon adenocarcinoma, syngeneic with WAG/Rij rats. This
ell line is well studied and has been proven to provide a tumor–
ost model similar to human colorectal carcinogenesis (11). Cells
ere grown as a stationary cell line in plastic culture flasks in
PMI 1640 medium, buffered with HEPES (20 mM) (Invitrogen
orporation, Gibco, Ghent, Belgium) additionally supplemented
ith 10% fetal calf serum, 4 mM L-glutamine, 50 U/mL penicillin,
nd 50 g/mL streptomycin at 37°C in a humidified atmosphere
ith 5% CO2 in the air. The cells were transferred at 95% con-
uency. Two million cells suspended in 0.2 mL were injected
ubcutaneously in the upper hind leg. Tumors reached a size of
.5–1 cm after a period of 4 weeks. After tumor growth of
inimally 8 mm diameter was observed, a jugular vein catheter
as inserted and tunneled to the interscapular region. To maintain
atheter delivery function between the first and second MRI,
ontinuous infusion at 0.5 mL saline/h was administered with a
age-mounted swivel and flexible metal tether system (Uno BV,
idam, The Netherlands), allowing the animal full mobility. To
nable histologic assessment, animals were sacrificed by anesthetic
verdose after the last in vivo measurements.
adiotherapy
Rats were not sedated and the tumor-bearing hind leg was immo-ilized using a Plexiglas holder, as described previously (12, 13).riefly, rats were placed in a purpose-built Plexiglas holder in prone
osition. The hind legs were pulled through an opening in the
older and immobilized with strings. Before each fraction, a radi-
tion field was simulated encompassing the tumor with a margin of
.5 cm. The photon irradiation was performed with a 5 MV linear
ccelerator (Elekta, Crawley, UK). Five fractions of 5 Gy (total
ose, 25 Gy) were delivered on 5 consecutive days. Because the
umors were inoculated subcutaneously, they were covered with
issue-equivalent silicone bolus of 1 cm to prevent the buildup
ffect under the skin. One single direct field at a fixed source-skin
istance of 100 cm was used. The dose was calculated to the
idpoint of the tumors according to their volume in each individ-
al animal, as obtained during simulation. DCE-MRI and oxygen-
tion measurements were performed before and 5 days after the
ompletion of RT.
RI
T1 weighted DCE-MRI was performed on a clinical Siemens
agnetom Symphony 1.5 Tesla scanner (Siemens AG, Erlangen,
ermany). Animals were sedated with 0.2–0.4 mL of medetomi-
ine (Domitor, Novartis Animal Health, Basel, Switzerland). Im-
ging comprised a single axial slice that was positioned through
oth upper limbs and the center of the tumor. Before the contrast
eries, T1 zero time maps were constructed from two spin echo
equences with different repetition times (repetition time, 1000 ms
nd 318 ms, respectively). Details of this sequence were as fol-
ows: slice thickness 3 mm, field of view 140  88, matrix size
56 160, echo time 20 ms, and flip angle 90°. Dynamic imaging
as performed with a four-antenna wrist coil (diameter, 10 cm)
sing an IR-TurboFLASH sequence. Details of the pulse se-
uence were as follows: temporal resolution 1.1 s (i.e., repetition
ime, 1100 ms), field of view 140  88, matrix size 256  160,
lice thickness 5 mm, echo time 4.08 ms, inversion time 560 ms,
nd flip angle: 12°. A bolus injection of 35–50 M Gd/Kg of P792
as manually injected as fast as possible (approximately 1 mL/s)
hrough the central venous line after the fourth scan. A total of 500
mages were obtained for a total scan time of 550 s.
nalysis of MR images
Postprocessing was performed using the research mode of a
ommercially available software tool (MIStar, Apollo Medical
maging, Melbourne, Australia).
The maximum cross sectional area (in cm2) of each tumor was
ecorded before and after RT.
Both a qualitative description of the tissue enhancement curve
nd a two-compartment pharmacokinetic approach according to
ofts and Kermode were implemented (7). In each tumor, regions
f interest were drawn encompassing the following regions: (1) the
ntire tumor, (2) the angiogenic tumor rim defined as the outer 2–3
oxel wide circumference, (3) the central necrotic area, and (4)
uscle tissue in the contralateral non irradiated hind leg.
In each region, the area under the enhancement curve (AUC)
as calculated until 550 s after contrast arrival.
Pharmacokinetic modeling was based on a two-compartment
odel consisting of a vascular space and an EES fraction that is
ntered by the CA leaking through the microvascular wall. Derived
rom a first-order differential equation describing contrast agent
ux driven by Fick’s law of diffusion, the concentration of CA in
he tissue (Ct in mM) is described by the following equation:
t Ktrans ′CtKtrans0 Cpt′e ve t  t dt′
wf
a
b
i
t
t
w
t
c
T
m
t
i
a
M
d
l
r
k
r
h
G
h
s
s
P
e
T
p
(
fi
t
c
w
i
s

(
e
s
2
H
t
p
d
I
g
s
n
p
(
e
b
O
(
h
c
c
s
n
3
w
s
n
e
a
B
V
b
m
0
(

i
S
s
1190 I. J. Radiation Oncology ● Biology ● Physics Volume 64, Number 4, 2006here Ktrans (min1) denotes the endothelial transfer rate, ve the
raction of the interstitial space (dimensionless) entered by the CA,
nd Cp the plasma concentration (in mM). In each tumor both
efore and after RT, the pixel with the most representative arterial
nput function was manually selected from the femoral artery of
he tumor bearing leg or the opposite leg to provide Cp(t). Mean
umor tissue and arterial T1 zero (before contrast injection) values
ere calculated from the T1 zero maps. These data, together with
he selected arterial input function, were used as the input for a
urve fitting routine resulting in parametric maps of Ktrans and ve.
he influence of inflow effects on leakage measurements was
inimized by using a deconvolution method in the model to separate
he inflow component from the tissue concentration Ct (7).
Quantitative values for all pixels in the four different regions of
nterest described above were exported to a spreadsheet for further
nalysis.
R contrast medium
Dynamic contrast studies were performed with P792 (Ga-
omelitol, Vistarem, Guerbet, Roissy, France), a new monogado-
inated rapid clearance MRI blood-pool agent that is cleared by
enal elimination. The molecular weight of the compound is 6.47
D, but the mean diameter of P792 is 50.5 Angstrom and the T1
elaxivity of this agent is 29 mM-1s-1 at 60 MHz (14). Apparent
ydrodynamic volume of P792 is 125 times greater than that of
d-DOTA (gadoterate meglumine, Dotarem); as a result of this
igh molecular volume, P792 is characterized by a limited diffu-
ion across normal endothelium and is therefore ideally suited to
tudy hyperpermeable neoplastic vessels (14). Experimentally,
792 has been used to study permeability effects of antiangiogen-
sis therapy in a prostate cancer model (15).
issue pO2 measurements
Tissue oxygenation was measured in both the tumor core and
eriphery with a fiberoptic probe based on fluorescence quenching
OxyLite, Oxford Optronix, Oxford, UK) (16, 17). A precalibrated
beroptic probe (diameter, 280 m) was inserted 5 mm deep into the
umor using a Seldinger technique. This involved insertion of a
atheter with needle assembly into the tissue; the needle was then
ithdrawn leaving the catheter in place, through which the probe was
nserted in such a way that the probe’s tip was exposed to the
urrounding tissue. The probe was then withdrawn in 40 steps of 100
m each over a total distance of 4 mm using a micromanipulator
model MN151, Narishige International Ltd, London, UK). After
Fig. 1. Typical enhancement pattern in different color
(b) fractionated radiotherapy. Curves represent changes in signach micromanipulator movement, measurements were started as
oon as a stable reading was obtained. Tissue pO2 was sampled every
s. Histograms were constructed based on the pO2 (expressed in mm
g) readings over the central 1 mm (core) and outer 1 mm (periphery)
rajectory. Both before and after RT, the hypoxic fraction (defined as
ercentage of pO2 measurements with a value of 5 mm Hg) was
etermined.
mmunohistochemistry
Immunohistochemistry was performed on the experimental
roup and on nine untreated control rats bearing tumors of similar
ize. From each tumor, half of the tissue was snap frozen in liquid
itrogen; the other part was fixed in 4% formalin and embedded in
araffin wax in the conventional manner. Microvascular density
MVD) was determined with a method modified after Weidner
t al. (18) After incubating 5 m frozen slices with anti-CD31 anti-
odies (mouse anti rat CD31, clone number TLD-3A12, Serotec,
xford, UK), the entire tumor section was scanned at low power
objective, 40) to identify “hot spots,” which are the areas of
ighest neovascularization. Individual microvessels were then
ounted under higher power (objective, 400) to obtain a vessel
ount in a defined area, and the average vessel count in three hot
pots was taken as the MVD.
For hypoxia staining, rats were injected with 60 mg/kg intrave-
ous pimonidazole (Hydroxyprobe Kit, Biognost, Heule, Belgium)
0 min before sacrifice. Paraffin-embedded slides were incubated
ith antipimonidazole antibodies and the resulting cytoplasmic
taining was expressed semiquantitatively. Membrane staining was
ot observed. Immunoassaying was visualized using 3-amino-9-
thylcarbazole (Dako, Glostrup, Denmark).
VEGF expression was assessed after incubating slides with mouse
nti-human VEGF C1 monoclonal antibody (sc-7269, Santa Cruz
iotechnology Inc., Santa Cruz, CA). The antibody used reacts with
EGF of mouse, rat, and human origin. Semiquantitative scoring of
oth pimonidazole staining and VEGF expression was based on a
ethod modified after Coppola et al. (19), with a scale ranging from
to 6. The scale was based on scoring of the fraction of positive cells
0: all cells negative; 1: 33% positive; 2: 33–66% positive; 3:
66% positive) and the staining intensity (1: weak; 2: moderate; 3:
ntense). Both scores were added to a maximum score of 6.
tatistical analysis
Data were analyzed and presented graphically with a statistical
oftware package (S-PLUS 6.1 for Windows, Insightful Corporation,
umor regions and normal muscle before (a) and afterectal t
al enhancement in a single tumor.
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1191DCE-MRI in a colorectal tumor model ● W. CEELEN et al.eattle, WA). Differences in signal enhancement parameters between
our tissue regions were evaluated with one-way analysis of variance.
ifferences in imaging parameters and pO2 before vs. after RT were
ssessed with the paired-sample t test or, when data were not normally
istributed, with the Wilcoxon signed-rank test. Differences in MVD
etween RT-treated rats and control rats were analyzed with the
npaired t test, whereas differences in pimonidazole staining score
nd VEGF expression were analyzed with the Mann-Whitney U test.
orrelation analyses between imaging, oxygenation, and histologic
ata were performed with the Spearman rank order test. Statistical
ignificance was inferred when p 0.05. Data are expressed as mean
95% confidence interval) unless stated otherwise.
Fig. 2. Cumulative signal intensity and pharmacokine
compared with normal muscle. AUC  area under the curve.RESULTS
ffect of RT on tumor growth
The mean cross-sectional surface area of the tumor did
ot change significantly during RT: 1.5 (0.9–2.1) cm2 be-
ore RT and 1.6 (0.8–2.4) cm2 after RT (p  0.9).
nhancement of neoplastic vs. normal tissue
A similar temporal enhancement pattern was observed in
ll animals (Fig. 1) confirming selective MRI enhancement
f tumor tissue by P792. Before RT, the arterial input
ameters before radiotherapy. *Statistically significanttic par
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1192 I. J. Radiation Oncology ● Biology ● Physics Volume 64, Number 4, 2006unction tended to peak at approximately 100–120 s. Signal
nhancement in neoplastic tissue was characterized by a
hort initial rapid increase of signal intensity corresponding
o the first arterial inflow and initial rapid inwash in the
umor tissue. This 20–25 s phase was followed in tumor
issue by a slowly rising signal intensity increase, which was
ost pronounced in the tumor rim. The tumor center dis-
layed a similar slow uptake, although the signal intensity
as much lower. Normal muscle, however, did not enhance
fter the initial fast uptake phase.
Cumulative DCE parameter values before RT are illus-
rated in Fig. 2. Mean AUC of signal intensity was signif-
cantly different between entire tumor, tumor rim, tumor
ore, and normal muscle (p  0.001 for all comparisons).
oth pharmacokinetic parameters were significantly dif-
erent between the entire tumor, tumor rim, and tumor
ore (p  0.001 for all comparisons), with the highest
Fig. 3. Parametric map (tumor masked) of Ktrans (1000
radiotherapy. The arrow points to the pixel containing t
Table 1. Comparison of pharmacokinetic c
radiotherapy (RT) in
Parameter
Region of
interest
Before
Mean
Ktrans (*103*min–1) Tumor 14.6
Rim 26.3
Core 5.4
Muscle 3.3
Ve Tumor 20.3
Rim 32.7
Core 6.3
Muscle 1.2 0trans observed at the tumor rim. No significant differences
n pharmacokinetic parameters were seen between the tu-
or core and normal muscle (p 0.4 for both Ktrans and ve).
ffects of fractionated RT on pharmacokinetic
CE-MRI parameters
The effects of fractionated RT were first evaluated graph-
cally with parametric maps of the tumor (Fig. 3a and 3b).
Both Ktrans and ve were significantly lower after RT in all
hree examined regions of the tumor (Table 1). In nonirra-
iated muscle tissue, on the contrary, no changes were
bserved in Ktrans or ve.
ffects of fractionated RT on tumor tissue pO2
The mean number of pO2 readings per animal was 839
efore RT and 706 after RT. Mean pO2 values in both tumor
egions before and after RT are illustrated in Table 2 and
before (a) and 5 days after (b) 5  5 Gy of fractionated
cted arterial input function.
enhancement parameters before and after
nt regions of interest
therapy After radiotherapy
5% CI Mean 95% CI p
.1–15.1 3.8 3.6–3.9 0.0001
.5–28.1 4.5 4.2–4.9 0.0001
.6–6.1 1.8 1.5–2.1 0.0001
.7–4.7 2.1 1.9–2.3 0.12
.1–21.5 2.4 1.9–2.8 0.0001
.2–36.1 5.8 4.3–7.3 0.0001
.8–8.8 0.5 0–1.1 0.0001/min)ontrast
differe
radio
9
14
24
4
1
19
29
3
.3–2.1 0.8 0.3–1.3 0.41
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1193DCE-MRI in a colorectal tumor model ● W. CEELEN et al.ig. 4. Both before and after RT, the tumor core was
ignificantly more hypoxic compared with the tumor rim.
ractionated RT significantly increased mean pO2 in both
umor core and rim. The hypoxic fraction (pO25 mm Hg)
n the tumor core was 79.2% before and 61.9% after RT
p  0.008). In the tumor rim, the hypoxic fraction was
6.6% before RT and 29.9% after RT (p  0.3).
Fig. 4. Frequency histogram of cumulative pO readings
Table 2. Comparison of tissue pO2 in the tumor rim and core
before and after fractionated radiotherapy
Tissue pO2 (mm Hg)
Before
radiotherapy
After
radiotherapy
Mean 95% CI Mean 95% CI p
umor rim 6.8 6.7–6.8 7.7 7.6–7.8 0.001
umor core 3.5 3.4–3.5 4.4 4.3–4.4 0.001
0.001 0.0012
tumor rim (b), before RT in the tumor core (c), and after RTThe histogram of cumulative pO2 readings showed a
imodal distribution in both tumor regions.
omparison of MVD, pimonidazole staining, and VEGF
xpression between irradiated and nonirradiated tumor
earing control rats
Expression of VEGF was significantly higher in RT-treated
ats in both tumor rim and core. The pimonidazole hypoxia
core, however, did not significantly differ between RT-treated
nd control animals. In the tumor rim, mean MVD was lower
n RT-treated animals, but the difference did not reach statis-
ical significance. In the tumor core, MVD was significantly
ower compared with the tumor rim, but did not differ between
ontrol and RT-treated animals (Table 3).
tatistical correlation of DCE-MRI parameters with pO2
nd histologic parameters in the tumor rim after RT
After RT, pO2 in the tumor rim was inversely related to
trans (r0.57, p 0.085) and ve (r0.65, p 0.04)
radiotherapy (RT) in the tumor rim (a), after RT in thebefore
in the tumor core (d).
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1194 I. J. Radiation Oncology ● Biology ● Physics Volume 64, Number 4, 2006Fig. 5). No correlation, however, was found between pO2
nd signal intensity AUC after RT. Similarly, no significant
orrelations were found between DCE-MRI parameters and
istologic parameters (MVD, VEGF expression, pimonida-
ole hypoxia score).
DISCUSSION
Tumor vessels display ultrastructural abnormalities in-
luding transcellular openings, widened interendothelial
unctions, abnormal endothelial cells, and absent basement
embrane that increase permeability even for large mole-
ules (20). In this study, we examined the use of P792, a
ew macromolecular CA, to measure changes in neovascu-
ar leakage induced by fractionated short-term RT. Neovas-
ular leakage is an important physiologic tumor parameter
hat has been shown to respond quickly and dramatically to
ntiangiogenesis interventions (21). Leakage of contrast
gent is determined both by endothelial permeability and by
he total exchange surface area (proportional to the number
Table 3. Comparison of pimonidazole hypoxia score,
microvascular density (MVD), and vascular endothelial growth
factor (VEGF) expression between radiotherapy-treated rats
and control rats bearing a tumor of similar size
Controls
Radiotherapy
treated p
EGF expression score
(median)
Tumor rim 2 5 0.005
Tumor core 2 5 0.018
ypoxia score (median)
Tumor rim 4 3.5 0.33
Tumor core 4.5 4 0.79
VD (mean)
Tumor rim 16.9 10.4 0.061
Tumor core 5.3 6.1 0.33Fig. 5. Correlation of Ktrans (a) and Ve (b)f functional vessels). Microvessel counts were performed
o differentiate permeability effects of RT from changes in
he total surface area. To optimize imaging parameters
escribing the contrast agent dynamics, a high temporal
esolution scanning method was used with contrast admin-
stered as a rapid central venous bolus (22). DCE-MRI was
ompared with invasive pO2 mapping. The fluorescence
ifetime method we have used to measure pO2 has several
dvantages over the Eppendorf device, including absence of
xygen consumption and increased accuracy at low oxygen
ensions common in neoplastic tissue (23). We chose to
tudy post-RT effects relatively early to reflect clinical
ractice, with surgery after short term RT being usually
erformed within 1 week after the end of therapy.
Our main finding is a significant reduction of Ktrans after
hort-term fractionated RT. Although the MVD did not
iffer significantly between RT-treated and control animals,
trend toward lower MVD in irradiated rats was present.
lthough the present analysis of a small number of animals
oes not allow us to draw a definitive conclusion, probably
oth altered endothelial permeability and a change in total
icrovascular surface area contribute to the decreased Ktrans
fter RT. Expression of VEGF was significantly higher in
T-treated rats compared with control animals. Hypoxia as
trigger of VEGF expression was decreased after RT in this
odel. However, other radiation-induced activators of VEGF
xpression such as the mitogen activated protein kinase path-
ay have been shown to enhance VEGF expression after RT
24). Overexpression of VEGF after RT has also been
linically demonstrated in rectal cancer patients (25).
Published experimental data suggest that, depending on
he dose and fractionation of RT and the timing of perme-
bility measurement, neovascular permeability can be either
ncreased or decreased (26). Large, single RT doses disrupt
he endothelial lining and cause a short-term increase in
ndothelial permeability. Smaller or fractionated doses,
owever, tend to decrease vascular permeability or cause nowith oxygenation after radiotherapy.
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1195DCE-MRI in a colorectal tumor model ● W. CEELEN et al.hange in this parameter. Several authors have used DCE-
RI to study the effects of RT on microvascular physiol-
gy. Yu et al. used DCE-MRI with gadopentetate dimeglu-
ine (Gd-DTPA) and the macromolecular CA gadomer-17
o study microvascular permeability in a rat adenocarci-
oma model (27). They observed a 67% decrease in per-
eability measured using gadomer-17 at 3 days after a
ingle dose of 5 Gy, whereas no change was observed after
dose of 20 Gy. No changes in permeability were observed
ith either dose of RT when Gd-DTPA was used as a
ontrast agent. Kobayashi et al. studied neovascular perme-
bility with a macromolecular CA after a single dose of RT
r fractionated RT (28). They found an increased perme-
bility after a single dose of 15 Gy, whereas permeability
as unaffected by fractionated RT.
Several clinical studies have used DCE-MRI with small
olecular weight MRI contrast agents to study tumor mi-
roenvironment during rectal cancer therapy. George et al.
ound a significant relation between pretreatment Ktrans as-
essed with Gd-DTPA and response to neoadjuvant chemo-
adiation (29). Responsive tumors showed a marked reduc-
ion in Ktrans at the end of treatment (mean logarithmic
trans0.46 vs. 0.86; p 0.04). It should be noted that with
he use of Gd-DTPA, Ktrans probably represents both per-
eability and microvascular flow. Gd-DTPA as a contrast
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